Facebook
Twitter
LinkedIn
ForwardClick here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.50 Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review the epidemiology and etiology of common tick-borne illnesses across the United States. The common presentations of various tick-borne infections are included. Clinical case scenarios are utilized to demonstrate appropriate diagnosis and treatment of tick-borne illnesses.
- FREE for Members
- Infectious Disease
- Pharmacology CE
- 0.50 Contact hours
$0.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
This session will review evidence-based practice for the diagnosis and treatment of Group A Streptococcus. Learn about the importance of utilizing the Modified Centor Score to determine when to test for Group A Strep. Review evidence for appropriate antibiotic treatment for Group A Strep. Apply this new knowledge to clinical case scenarios.
- FREE for Members
- Infectious Disease
- 0.75 Contact hours
$0.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
Does addressing Covid-19 vaccine hesitancy in your practice present a challenge? NAPNAP’s COVID-19 continuing education course provides a current, research-based approach to helping parents navigate the huge amounts of misinformation and disinformation about COVID-19 and vaccination.
- Primary Care
- FREE for Members
- Infectious Disease
- 1.25 Contact hours
$0.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered free for NAPNAP Members and for non- members.
This 4-part series will enable front-line clinicians to recognize, diagnose, and treat Lyme disease, an increasingly common tickborne illness. The free online curriculum will be a valuable resource for primary care clinicians, public health professionals, pharmacists, and health educators who encounter clients with Lyme disease.
- Primary Care
- FREE for Members
- Infectious Disease
- 1.00 Contact hours
$0.00
1.00 NAPNAP Contact Hour. This continuing education activity is offered free for NAPNAP Members and for non- members.
This 4-part series will enable front-line clinicians to recognize, diagnose, and treat Lyme disease, an increasingly common tickborne illness. The free online curriculum will be a valuable resource for primary care clinicians, public health professionals, pharmacists, and health educators who encounter clients with Lyme disease.
- Primary Care
- FREE for Members
- Infectious Disease
- 1.25 Contact hours
$0.00
1.25 NAPNAP Contact Hour. This continuing education activity is offered free for NAPNAP Members and for non- members.
This 4-part series will enable front-line clinicians to recognize, diagnose, and treat Lyme disease, an increasingly common tickborne illness. The free online curriculum will be a valuable resource for primary care clinicians, public health professionals, pharmacists, and health educators who encounter clients with Lyme disease.
- Primary Care
- FREE for Members
- Infectious Disease
- 1.00 Contact hours
$0.00
1.00 NAPNAP Contact Hour. This continuing education activity is offered free for NAPNAP Members and for non- members.
This 4-part series will enable front-line clinicians to recognize, diagnose, and treat Lyme disease, an increasingly common tickborne illness. The free online curriculum will be a valuable resource for primary care clinicians, public health professionals, pharmacists, and health educators who encounter clients with Lyme disease.
- Primary Care
- 1.00 Contact hours
$0.00
New insights into the immunopathology of FA have led to development of cautious use of controlled exposure to food allergens through allergen immunotherapy and emerging use of monoclonal antibody therapy to interfere with the synthesis of immunoglobulin E (IgE). The expert faculty will contextualize the mechanisms and available clinical trial data related to the use of biologic agents in FA as monotherapy and as adjunct therapy to allergen immunotherapy.